v3.25.1
Consolidated Statements of Cash Flows - CAD ($)
12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Cash flows used in operating activities      
Net income (loss) $ (893,717) $ (637,809) $ (1,769,501)
Adjustments to reconcile net loss to net cash used in operating activities      
Accretion expense 38,220 0 0
Interest on notes payable 177,956 189,926 162,724
Amortization expense 10,451 15,797 18,918
Foreign exchange, non-cash 5,498 19,358 (39,124)
Foregiveness of debt (24,916) 0 0
Impairment of exploration and evaluation assets 0 0 55,885
Share-based compensation for consulting services 0 0 2,393
Adjustments for share-based payments 46,376 0 0
Write-off of equipment (263) 0 0
Changes in operating assets and liabilities      
Increase (decrease) Prepaids and other receivables (15,598) 50,766 25,221
Increase (decrease) accounts payable 43,053 63,248 54,868
AdjustmentsForDecreaseIncreaseInAccruedLiabilities 43,448 (24,849) (23,488)
Increase (decrease) in due to related parties 90,123 162,095 226,849
Net cash used in operating activities (478,843) (161,468) (1,285,255)
Cash flows used in investing activities      
Acquisition of exploration and evaluation assets (5,000) 0 0
Acquisition of equipment 0 0 (55,572)
Net cash used in investing activities (5,000) 0 (55,572)
Cash flows provided by financing activities      
Issuance of notes payable to related parties 297,425 167,583 459,580
Cash received on subscription to shares, net 460,700 0 461,300
Payment of shares issuance costs (35,350) 0 (34,301)
Net cash provided by financing activities 722,775 167,583 886,579
Effects of foreign currency exchange on cash 147 (1,192) 707
Increase (decrease) in cash 239,079 4,923 (453,541)
Cash and Cash equivalents 25,699 20,776 474,317
Cash and Cash equivalents 264,778 25,699 20,776
Non-cash transactions      
Exploration and evaluation assets included in accounts payable 8,000 0 0
Shares issued for exploration and evaluation assets, value $ 245,500 $ 0 $ 0